Molecular radiotherapy for adult type metastatic neuroendocrine tumours in children
Molecular radiotherapy can be beneficial, and may provide good disease control for long periods in a proportion of these patients. Combining different radiopharmaceuticals may be of value.
Authors
- Jamshed Bomanji (ORCID: https://orcid.org/0000-0002-4289-903X)
- J. Gains
- Huang Hian Liang
- Simon Wan (ORCID: https://orcid.org/0000-0003-2368-732X)
- Connie Peet
- Caroline Elmaraghi (ORCID: https://orcid.org/0000-0001-9975-4408)
- Trung Van Nguyen (ORCID: https://orcid.org/0000-0003-3363-5064)
- Tarek Abdel‐Aziz (ORCID: https://orcid.org/0000-0001-7630-9985)
- Mark N. Gaze (ORCID: https://orcid.org/0000-0002-8344-7902)
Institutions
- University College London Hospitals NHS Foundation Trust (GB)
- University College London (GB)
Publication Details
- Journal
- European Journal of Nuclear Medicine and Molecular Imaging
- Published
- 2025-04-24
- DOI
- https://doi.org/10.1007/s00259-025-07247-6
- Primary Topic
- Neuroendocrine Tumor Research Advances
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Cancer Research UK